The NADH-ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are associated with autism

Acta Psychiatrica Scandinavica

Volumn 123, Issue 2, 2011, Pages 118-124

  Marui, T ^a,b   Funatogawa, I ^c   Koishi, S ^d   Yamamoto, K ^e   Matsumoto, H ^f   Hashimoto, O ^g   Jinde, S ^a   Nishida, H ^h   Sugiyama, T ^d   Kasai, K ^a   Watanabe, K ⁱ   Kano, Y ⁱ   Kato, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g AINO UNIVERSITY   (Japan)

^h Asunaro Hospital for Child and Adolescent Psychiatry   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

Author keywords

Association study; Autism; Haplotype block; NDUFA5 gene

Indexed keywords

NADH UBIQUINONE OXIDOREDUCTASE 1 ALPHA SUBCOMPLEX 5; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; NADH DEHYDROGENASE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 78650794351     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2010.01600.x     Document Type: Article

References (24)

1. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001;2:943-955.
2. Rutter M, Silberg J, O'connor T et al. Genetics and child psychiatry: II Empirical research findings. J Child Psychol Psychiatry 1999;40:19-55.
3. Bailey A, Le Couteur A, Gottesman I et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
4. Pickles A, Bolton P, Macdonald H et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 1995;57:717-726.
5. Risch N, Spiker D, Lotspeich L et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999;65:493-507.
6. Lombard J. Autism: a mitochondrial disorder? Med Hypotheses 1998;50:497-500.
7. Scholte HR. The biochemical basis of mitochondrial diseases. J Bioenerg Biomembr 1988;20:161-191.
8. Coleman M, Blass JP. Autism and lactic acidosis. J Autism Dev Disord 1985;15:1-8.
9. Haas RH, Light M, Rice M et al. Oxidative metabolism in Rett syndrome: 1. Clinical studies. Neuropediatrics 1995;26:90-94.
10. Pons R, Andreu AL, Checcarelli N et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 2004;144:81-85.
11. Filipek PA, Juranek J, Smith M et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 2003;53:801-804.
12. Russell MW, Du Manoir S, Collins FS et al. Cloning of the human NADH: ubiquinone oxidoreductase subunit B13: localization to chromosome 7q32 and identification of a pseudogene on 11p15, Mamm. Genome 1997;8: 60-61.
13. Izutsu T, Osada H, Tachimori H et al. The usefulness of the child behavior questionnaire revised (CBQ-R) as a supplementary scale for diagnosis of pervasive developmental disorders. Rinsyo-Seishin Igaku 2001;30:525-532.
14. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
15. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
16. Clayton D, Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet 1999;65:1161-1169.
17. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: candidate-gene approaches for studying complex genetic traits:practical considerations. Nat Rev Genet 2002;3:391-397.
18. Cohen-Woods S, Schosser A, Mcguffin P. From age correction to genome-wide association. Acta Psychiatr Scand 2009;120:355-362.
19. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99.
20. Liu PY, Zhang YY, Lu Y et al. A survey of haplotype variants at several disease candidategenes: the importance of rare variants for complex diseases. J Med Genet 2005;42:221-227.
21. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701.
22. Marui T, Koishi S, Funatogawa I et al. No association of FOXP2 and PTPRZ1 on 7q31 with autism from the Japanese population. Neurosci Res 2005;53:91-94.
23. Marui T, Koishi S, Funatogawa I et al. No association between the neuronal pentraxin II gene polymorphism and autism. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:940-943.
24. Marui T, Funatogawa I, Koishi S et al. Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study. Brain Dev 2007;29:510-513.